Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 8/18/15 → 8/17/18 |
Funding
- Merck Sharp and Cohme Corporation: $11,250.00
V114-005 A Phase l-ll, randomized, Double-Blind, Study to Evaluate the safety, Tolerability, and Immunogenicity of Different formulations of V114 in Healthy Adults and Infants
- Rupp, Richard (PI)
Project: Research project